| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 06/29/2006 | WO2006067392A2 Indole derivatives for the treatment of tuberculosis |
| 06/29/2006 | WO2006066950A2 Tricyclic aminoalcohols, methods for producing the same and their use as anti-inflammatory agents |
| 06/29/2006 | WO2006066948A1 Piperidine derivatives as antagonists of the cc chemokine receptor ccr1 and their use as anti-inflammatory agents |
| 06/29/2006 | WO2006066896A2 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 06/29/2006 | WO2006066885A1 Substituted n-heterocyclic compounds and their use as dopamine d3 receptor ligands |
| 06/29/2006 | WO2006066879A2 Compounds with kv4 ion channel activity |
| 06/29/2006 | WO2004047745A3 3-(pyridinyl-piperazin-1-yl)-phenylethyl amides as potassium channel openers |
| 06/29/2006 | US20060142380 oxidizing (4-Chloro-2-fluorophenoxy)-6-methyl-2-[4-(methylthio)phenyl]-4H-pyran-4-one with an oxidizer selected from sodim metaperiodate and a mixture of titanium teteraisoperoxide, tert-butyl hydroperoxide and diethyl tartrate; 3-(2,4-Difluorophenoxy)-6-methyl-2-[4-(methylsulfinyl)phenyl]-4H-pyran-4-one |
| 06/29/2006 | US20060142369 Delta 1-pyrrolines used as pesticides |
| 06/29/2006 | US20060142365 Benzimidazole compounds and antiviral uses thereof |
| 06/29/2006 | US20060142347 Compounds and methods for the treatment or prevention of Flavivirus infections |
| 06/29/2006 | US20060142343 Pyrrolines |
| 06/29/2006 | US20060142334 Tetrahydroquinoline derivatives |
| 06/29/2006 | US20060142333 e.g. N-(1-Methyl-1,2,3,4-tetrahydroquinolin-7-yl)-1,1'-biphenyl-4-carboxamide; capsaicin recepor antagonist; analgesic; neuropathic, postoperative, postrheumatoid arthritic, back, cancer pain, neuralgia, dental pain, headache, migraine, diabetic and HIV-related neuropathy |
| 06/29/2006 | US20060142329 Substituted fused N-heteroaryl compounds such as imidazo[1,5a]- or [1,2s]pyridines, e.g., 3-[3-(Pyrrolylphenoxy-2-hydroxypropyl)aminoalkyl]imidazo[1,5-a]pyridine derivatives, especially HCl salts; treating obesity and type 2 diabetes |
| 06/29/2006 | US20060142328 Beta 3 adrenergic agonists |
| 06/29/2006 | US20060142327 Beta 3 adrenergic agonists |
| 06/29/2006 | US20060142314 2-substituted-4-(indazol-5-ylamino)-6,7-dimethoxyquinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction |
| 06/29/2006 | US20060142313 2-substituted-4-(indazolamino)quinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction |
| 06/29/2006 | US20060142293 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis |
| 06/29/2006 | US20060142277 Substituted aralkyl derivatives |
| 06/29/2006 | CA2592462A1 Tricyclic delta-opioid modulators |
| 06/29/2006 | CA2592378A1 3-cycloalkylcarbonyl indoles as cannabinoid receptor ligands |
| 06/29/2006 | CA2591208A1 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 06/29/2006 | CA2591117A1 Novel heteroarylacetamides |
| 06/29/2006 | CA2589331A1 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 06/29/2006 | CA2587664A1 Compounds with kv4 ion channel activity |
| 06/29/2006 | CA2586973A1 Tricyclic amino alcohols, processes for synthesis of same and use of same as anti-inflammatory drugs |
| 06/28/2006 | EP1674465A1 Process for obtaining enantiomers of thienylazolylalcoxyethanamines |
| 06/28/2006 | EP1674460A1 Chromene compound |
| 06/28/2006 | EP1674097A1 Compounds effecting glucokinase |
| 06/28/2006 | EP1673369A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 06/28/2006 | EP1673357A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 06/28/2006 | EP1673354A1 Arylindenopyridines and arylindenopyrimidines and their use as adenosine a2a receptor antagonists |
| 06/28/2006 | EP1673350A2 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides |
| 06/28/2006 | EP1673349A1 Benzimidazole derivates: preparation and pharmaceutical applications |
| 06/28/2006 | EP1673347A1 Substituted dibenzo-azepine and benzo-diazepine derivatives useful as gamma-secretase inhibitors |
| 06/28/2006 | EP1673090A1 Fused-aryl and heteroaryl derivatives and methods of their use |
| 06/28/2006 | EP1673084A1 1-2' (1,4'-biperidin-1'-yl)-1-(phenyl)-ethylcyclohexanol derivatives as monoamine reuptake modulators for the treatment of vasomotor symptoms |
| 06/28/2006 | EP1673059A2 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 06/28/2006 | EP1569900B1 Substituted 3-carbonyl-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/28/2006 | EP1569899B1 Substituted 3-alkyl- and 3-arylalkyl-1h-indol-1-yl-acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 06/28/2006 | EP1556377B1 Cyclopropyl-thienyl-carboxamide as fungicides |
| 06/28/2006 | EP1395261B1 Pyridylpyrimidine derivatives as effective compounds against prion diseases |
| 06/28/2006 | EP1255536B1 Indolinone derivatives for modulation of c-kit tyrosine protein kinase |
| 06/28/2006 | CN1795191A 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them |
| 06/28/2006 | CN1795190A Compounds and methods for the treatment or prevention of flavivirus infections |
| 06/28/2006 | CN1795180A Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 06/28/2006 | CN1795179A Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
| 06/28/2006 | CN1795178A Process for synthesizing heterocyclic compounds |
| 06/28/2006 | CN1795177A 1,2,4-substituerte 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 06/28/2006 | CN1795174A Novel substituted 3-sulfur indoles |
| 06/28/2006 | CN1261429C Cholesterol lowering benzo [b] thiophenes and benzo[d] isothiazoles |
| 06/28/2006 | CN1261099C Tetrahydroquinoline derivatives |
| 06/28/2006 | CN1261098C p38-alpha kinase inhibitors |
| 06/27/2006 | US7067670 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 06/27/2006 | US7067665 phenylethoxy-phenyl- or -pyridyl- (acet) amides, N-substituted with pyrimidine ring-containing (tetrahydro)pyridines or phenyl groups; e.g., 3-[2-(2,4-Dichloro-phenyl)-ethoxy]-4-methoxy-N-[4-(pyrimidin-2-ylsulfamoyl)-phenyl]-benzamide; treating cardiovascular disorders such as thromboses and restenoses |
| 06/27/2006 | US7067656 Sulfamoyl compounds and agricultural and horticultural fungicides |
| 06/27/2006 | US7067549 Pyrrolidone carboxamides |
| 06/27/2006 | US7067540 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 06/27/2006 | US7067534 Melanin-concentrating hormone; N-(N'-substituted indolyl)methyl-4-(m-alkylamidophenyl) piperidine; antidepressants, anxiolytic agents; obesity, incontinence |
| 06/27/2006 | US7067532 Substituted quinolines as antitumor agents |
| 06/27/2006 | US7067531 Quinolinone derivatives containing imidazole rings is useful as anticarcinogenic agent |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067516 Compounds used as antiinflammatory agents and enzyme inhibitors |
| 06/27/2006 | US7067512 Substituted 1,4-benzodiazepines and uses thereof |
| 06/27/2006 | US7067509 An urea derivative containing amide, amine or substitued amine groups and pyrrolidine ring(s), useful for treating obesity, anxiety or depression |
| 06/27/2006 | US7067506 Compounds useful for inhibiting Chk1 |
| 06/27/2006 | US7067305 Enzymatic process for the resolution for enantiomeric mixtures of β-lactams |
| 06/27/2006 | US7067202 Luminescent organometallic compound and light emitting device |
| 06/22/2006 | WO2006066197A1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 06/22/2006 | WO2006066172A1 Aminopyrimidine compounds and methods of use |
| 06/22/2006 | WO2006065946A1 Pyrid-2-ones useful as inhibitors of tec family protein kinases for the treatment of inflammatory, proliferative and immunologically-mediated diseases |
| 06/22/2006 | WO2006065480A2 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 06/22/2006 | WO2006065277A2 Heterocyclic aspartyl protease inhibitors |
| 06/22/2006 | WO2006064957A1 Amide compound and thrombopoietin receptor activator |
| 06/22/2006 | WO2006064757A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | WO2006064286A1 Cathepsin s inhibitors |
| 06/22/2006 | WO2006064251A1 4- (4- (imidazol-4-yl) pyrimidin-2-ylamino) benzamides as cdk inhibitors |
| 06/22/2006 | WO2006064044A1 Indolinones and their use as antiproliferative agents |
| 06/22/2006 | WO2006064031A1 Enantiomers of 3-heteroaryl-8h-8-azabicyclo(3.2.1)oct-2-ene and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/22/2006 | WO2006063863A1 Biaromatic compounds that modulate ppar type receptors, process for preparing them and use thereof in cosmetic or pharmaceutical compositions |
| 06/22/2006 | WO2006063700A1 1-arylpyrazoles and their use as pesticides |
| 06/22/2006 | US20060135787 Process for obtaining enantiomers of thienylazolylalcoxyethanamines |
| 06/22/2006 | US20060135771 Quinoline derivatives as nk-2 and nk-3 receptor antagonists |
| 06/22/2006 | US20060135769 Farnesyl transferase inhibiting 4-heterocyclyl-quinoline and quinazoline derivatives |
| 06/22/2006 | US20060135597 Administering a bithiophene substituted by a carboxyalkyl group and a pyridinyl or pyrimidinyl group to treat irritable bowel syndrome, chronic heart failure, angina, cardiac infarction, cerebral infarction, pollakiuria, urinary incontinence, or, cerebral ischemia |
| 06/22/2006 | US20060135591 Modulators of CRTH2 activity |
| 06/22/2006 | US20060135589 1h-Indazole-3-carboxamide compounds as cyclin dependent kinase (cdk) inhibitors |
| 06/22/2006 | US20060135568 Methods of treating microbial infections in humans and animals |
| 06/22/2006 | US20060135559 Novel imidazoline compounds |
| 06/22/2006 | US20060135554 Novel compounds |
| 06/22/2006 | US20060135543 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 06/22/2006 | US20060135532 Anticoagulants; antithrombotic agents in the treatment and prevention of thrombosis |
| 06/22/2006 | US20060135530 Such as (2E)-3-[3-(aminomethyl)-2-isobutyl-4-(4-methylphenyl)quinolin-6-yl]acrylamide; dipeptidyl peptidase IV inhibitors; diabetes, obesity, glucose intolerance |
| 06/22/2006 | US20060135522 Tricyclic delta-opioid modulators |
| 06/22/2006 | US20060135519 5-aryltetrazole compounds and compositions thereof |
| 06/22/2006 | US20060135515 Heterocyclic amides and their use treating thromboembolic diseases and tumors |
| 06/22/2006 | US20060135487 Piperazine derivatives and their use as anti-inflammatory agents |